Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis

Mohan, Pooja Basthi and Nagaraju, Shankar Prasad and Rangaswamy, Dharshan and Musunuri, Balaji and Prabhu, Ravindra A and Bhat, Ganesh and Shailesh, * and Shetty, Shiran (2021) Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis. Clinica Chimica Acta, 523. pp. 339-347. ISSN 0009-8981

[img] PDF
13747.pdf - Published Version
Restricted to Registered users only

Download (860kB) | Request a copy


Acute kidney injury (AKI) in liver cirrhosis is associated with poor clinical outcomes including an increased long and short-term mortality. The common type of AKI observed in patients with cirrhosis are prerenal AKI (PRA),hepatorenal syndrome (HRS) and acute tubular necrosis (ATN). Despite the growing knowledge and uniform definition for the diagnosis of AKI, there are several challenges including, early diagnosis and management.Precisely differentiating the type of AKI is critical, as therapies differ significantly. In this review, we summarize AKI in liver cirrhosis, their definition, pathophysiology and deficiencies of using the existing biomarker, serum creatinine. We outline the current clinical evidence on the novel biomarker urinary neutrophil gelatinaseassociated lipocalin (uNGAL) and its potential role as a biomarker in the early detection, differentiation and prognostication of AKI. This review also briefly talks about other forthcoming biomarkers which hold promise in the management of AKI in liver cirrhosis

Item Type: Article
Uncontrolled Keywords: Hepatorenal syndrome; Novel biomarker; Acute tubular necrosis; uNGAL; Liver cirrhosis
Subjects: Medicine > KMC Manipal > Gastroenterology
Medicine > KMC Manipal > Nephrology
Depositing User: KMC Library
Date Deposited: 25 Jan 2022 04:22
Last Modified: 25 Jan 2022 04:22
URI: http://eprints.manipal.edu/id/eprint/157834

Actions (login required)

View Item View Item